サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：免疫レパートリーシーケンシング市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測
市場調査レポート
商品コード
1290857

免疫レパートリーシーケンシング市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測

Immune Repertoire Sequencing Market with COVID-19 Impact Analysis, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 387 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
免疫レパートリーシーケンシング市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2023年06月01日
発行: AnalystView Market Insights
ページ情報: 英文 387 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

免疫レパートリーシーケンシング市場規模は2022年に13億1,580万米ドルとなり、2023年から2030年にかけてCAGR 7.7％で拡大

免疫レパートリーシーケンシング市場-市場力学

ファーマコゲノミクスに基づく薬剤回収に対する政府支援の増加が市場の需要を促進すると予想される

免疫レパートリーシーケンシングは、患者の免疫系と薬物療法に対する反応に関する追加的な知見を提供することで、薬理ゲノミクスを促進することができます。例えば、がん治療の観点から、免疫レパートリー配列決定は、免疫系によって認識される腫瘍特異的抗原の同定に役立ちます。しかし、がんやその他の感染症に対する免疫療法の需要の増加が、免疫レパートリーシーケンシング市場の成長を促進すると予想されます。免疫療法薬は、一部のがんでは他のがんよりもよく効き、一部の患者には奇跡となり得るが、すべての患者には効かないです。全体の奏効率は15～20％程度です。また、ジョンズ・ホプキンス医学によれば、がん免疫療法は1億米ドル以上の企業25社で構成される独自の株価指数を持っているほど、医薬品の研究開発が盛んです。

免疫レパートリーシーケンシング市場-主な洞察

  • 免疫レパートリーシーケンシング産業は、持続可能な成長に対する意識の高まりにより、著しい速度で成長すると予測される
  • 製品タイプ別では、アッセイキットが2022年に最大市場シェアを示すと予測される
  • 用途別では、がん免疫療法が2022年の主要タイプでした。
  • 地域別では、北米が2022年の主要収益源でした。

免疫レパートリーシーケンシング市場-セグメンテーション分析：

世界の免疫レパートリーシーケンシング市場は、製品タイプ、用途、技術、地域に基づいて区分されます。

市場は製品タイプに基づいて3つのカテゴリーに分けられる：機器とアッセイキット。アッセイキットが市場を独占する可能性が高いです。これらのキットには通常、サンプル調製、ライブラリー構築、シーケンス、データ解析のための試薬やプロトコールが含まれます。

市場はアプリケーションによって6つのカテゴリーに分けられる：がん免疫療法、バイオマーカー探索、自己免疫疾患、ワクチン開発と有効性、移植拒絶反応と寛容、感染症、その他です。がん免疫療法が市場を独占しており、予測期間中もその優位性は維持されるであろう。がん免疫療法は、がんと闘うために身体の免疫システムを利用する、急速に進歩している分野です。

免疫レパートリーシーケンシング市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国ごとにさらに分けられます。北米は、ヘルスケアインフラを改善するための政府資金の増加により、免疫レパートリーシーケンシング市場の成長を支配すると予想されています。医療・健康研究開発では、連邦政府の投資が米国の医療・健康研究開発全体の4分の1（25%）を占める615億米ドルで、2020年には国立衛生研究所（NIH）だけでこのような投資全体の20%（489億米ドル）を占めると予測しています。このレベルでは、NIHはバイオ製薬業界に次いで2番目に大きな医療・健康研究の資金提供者です。しかし、政府からの資金援助が増えれば、免疫レパートリーのシーケンスに関する研究を実施するためのリソースを研究者や研究機関に提供することができます。欧州とアジア太平洋地域は、研究開発と新規製品の上市が増加していることから、予測期間中に大きな成長が見込まれます。

免疫レパートリーシーケンシング市場-競合情勢：

免疫系の解明、疾患の進行、個別化治療の開発において重要な役割を果たすことから、免疫レパートリーシーケンシングに対する需要は着実に増加しています。各社は免疫レパートリー解析のためのシーケンス装置、試薬、ソフトウェアソリューションを提供しています。免疫レパートリーシーケンシング市場は競争が激しく、さまざまな企業や研究機関が技術革新を推進し、免疫レパートリーのシーケンスと解析のためのソリューションを提供しています。シーケンス技術、バイオインフォマティクスツール、データ解析手法の進歩が競争情勢を形成し続け、市場の成長に寄与しています。例えば、2023年、サーモフィッシャーサイエンティフィック社は、免疫応答系で重要な役割を果たすT細胞とB細胞の悪性クローンの可能性を検出するために設計されたIon Torrent Oncomine免疫レパートリーアッセイの新しい製品群を発表しました。

最近の動き

ファイザー社とAdaptive Biotechnologies Corporationは、適応免疫系の次世代シーケンシングを活用し、ファイザー社の成長中の免疫腫瘍学フランチャイズを発展させるためのトランスレーショナルリサーチの共同研究を開始しました。本契約に基づき、ファイザー社とアダプティブ社は、免疫療法の恩恵を優先的に受ける可能性のある患者を特定するために、医薬品開発とプラットフォーム技術のバイオマーカーに関する専門知識を組み合わせることを目指します。

研究の主な特徴

  • この調査レポートは、免疫レパートリーシーケンシング市場の市場規模、年間平均成長率（CAGR %）、2022年を基準年とした推定・予測（2023-2030年）を提供しています。
  • この調査レポートは、免疫レパートリーシーケンシング市場に関する最新の動向洞察を顧客に提供します。
  • 調査レポートは、異なるセグメント/国にわたる潜在的な成長機会を解明し、免疫レパートリーシーケンシング市場の魅力的な投資提案マトリクスを説明します。
  • 全体的なレポートは、新規投資機会、既存企業が直面する課題、免疫レパートリーシーケンシング市場で持続するための成長要因を特定します。
  • 免疫レパートリーシーケンシング市場規模、予測、CAGR、市場力学に対するCOVID-19の影響は、調査範囲の下で詳細に議論されています。COVID後の免疫レパートリーシーケンシング市場に関する詳細な洞察もカバーします。
  • 本レポートのユーザーに免疫レパートリーシーケンシング市場の包括的な見解を提供するために、免疫レパートリーシーケンシング市場の競合情勢と主要イノベーター分析も含めています。
  • 本調査では、市場規模、成長率、魅力度に基づいてすべての業界セグメントをベンチマークした成長見通しマッピング分析を網羅しています。
  • 主要市場参入企業を特集した詳細な企業プロファイルを提供しており、免疫レパートリーシーケンシング市場で事業を展開する企業の財務情報や戦略的イニシアチブを理解するのに役立ちます。
  • さらに、本レポートは、世界レベルだけでなく地域レベルで市場に関与する主要参入企業の重要な買収＆合併、提携＆ジョイントベンチャー、新発売、研究開発、地域展開も明らかにしています。
  • 免疫レパートリーシーケンシングの世界市場レポートは主に、サプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界のさまざまな利害関係者を対象としています。

目次

第1章 免疫レパートリーシーケンシング市場概要

  • 調査範囲

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 免疫レパートリーシーケンシングの主要な市場動向

  • 免疫レパートリーシーケンシングの市場促進要因
  • 免疫レパートリーシーケンシング市場抑制要因
  • 免疫レパートリーシーケンシングの市場機会
  • 免疫レパートリーシーケンシング市場の将来動向

第4章 免疫レパートリーシーケンシング業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 免疫レパートリーシーケンシング市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 免疫レパートリーシーケンシング市場情勢

  • 免疫レパートリーシーケンシング市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 確立された企業の分析
    • 新興企業の分析

第7章 免疫レパートリーシーケンシング市場- 製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 機器
    • アッセイキット

第8章 免疫レパートリーシーケンシング市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • がん免疫療法
    • バイオマーカーの発見
    • 自己免疫疾患
    • ワクチンの開発と有効性
    • 移植の拒絶反応と寛容
    • 感染症
    • その他

第9章 免疫レパートリーシーケンシング市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 免疫レパートリーシーケンシングの北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 免疫レパートリーシーケンシングの欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • 免疫レパートリーシーケンシングのアジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • 免疫レパートリーシーケンシングのラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 免疫レパートリーシーケンシングの中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- 免疫レパートリーシーケンシング業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Illumina Inc.
    • Thermo Fisher Scientific
    • PacBio
    • CD Genomics
    • Agilent Technologies, Inc
    • F. Hoffmann-La Roche Ltd
    • BGI Group Guangdong
    • Takara Bio, Inc.
    • Adaptive Biotechnologies
    • Juno Therapeutics
    • Atreca, Inc.
    • irepertoire, Inc.

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Immune Repertoire Sequencing Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Immune Repertoire Sequencing Market, by Product Type 2018-2030 (USD Million)
  • TABLE Immune Repertoire Sequencing Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Immune Repertoire Sequencing Market, by Application 2018-2030 (USD Million)
  • TABLE Immune Repertoire Sequencing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Immune Repertoire Sequencing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Immune Repertoire Sequencing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE Europe Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE Asia Pacific Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE Latin America Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE Middle East and Africa Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Immune Repertoire Sequencing Market share analysis by country, 2022
  • FIGURE Germany Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Immune Repertoire Sequencing Market share analysis by country, 2022
  • FIGURE India Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Immune Repertoire Sequencing Market share analysis by country, 2022
  • FIGURE Brazil Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Immune Repertoire Sequencing Market share analysis by country, 2022
  • FIGURE Saudi Arabia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1311

REPORT HIGHLIGHT

Immune Repertoire Sequencing Market size was valued at USD 1,315.8 million in 2022, expanding at a CAGR of 7.7% from 2023 to 2030.

Immune repertoire sequencing is a technique used to analyze the diversity and composition of the immune system's repertoire of antibodies or T cell receptors. Immune repertoire refers to all of the unique T-cell receptor and B-cell receptor genetic rearrangements within the adaptive immune system It has unique advantages compared to the more common diagnostic and prognostic techniques that predate it. The traditional strategies for studying the immune repertoire, which include spectating, Sanger sequencing et al., are laborious, costly, and insufficient for generating a high-resolution picture of the immune repertoire. For instance, specific disease prognoses can lead to the evolution of similar or identical CDR3s in different patients. CDR3 sequencing can thus potentially be used for diagnosis.

Immune Repertoire Sequencing Market- Market Dynamics

An increase in government support for pharmacogenomics-based drug recovery is expected to propel market demand

Immune repertoire sequencing can accessory pharmacogenomics by providing additional acumens into a patient's immune system and its response to drug therapies. For example, in the perspective of cancer treatment, immune repertoire sequencing can help identify tumor-specific antigens recognized by the immune system. However, the increase in demand for immunotherapy for cancer and other infectious diseases is expected to propel the growth of the Immune Repertoire Sequencing Market. Immunotherapy drugs work better in some cancers than others and while they can be a miracle for some, they fail to work for all patients. Overall response rates are about 15 to 20%. And also there is so much pharmaceutical R&D that cancer immunotherapy has its own stock index of 25 companies worth USD100 million or more, according to Johns Hopkins Medicine.

Immune Repertoire Sequencing Market- Key Insights

  • As per the analysis shared by our research analyst, the global Immune Repertoire Sequencing market is estimated to grow annually at a CAGR of around XX% over the forecast period (2023-2030)
  • The Immune Repertoire Sequencing industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on product type segmentation, Assay Kits was predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Cancer Immunotherapy was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Immune Repertoire Sequencing Market- Segmentation Analysis:

The Global Immune Repertoire Sequencing Market is segmented on the basis of Product Type, Application, Technology, and Region.

The market is divided into three categories based on product type: Instruments and Assay Kits. Assay Kits are likely to dominate the market. These kits typically include reagents and protocols for sample preparation, library construction, sequencing, and data analysis.

The market is divided into six categories based on application: Cancer Immunotherapy, Biomarker Discovery, Autoimmune Diseases, Vaccine Development and Efficacy, Transplant Rejection, and Tolerance, Infectious Diseases, and Others. Cancer Immunotherapy dominates the market and is likely to maintain its dominance during the forecast period. Cancer immunotherapy is a rapidly advancing field that utilizes the body's immune system to fight cancer.

Immune Repertoire Sequencing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Immune Repertoire Sequencing Market, due to rising Government Funding to Improve the Healthcare Infrastructure. Medical and Health Research and Development predicted that the Federal government investment accounts for one-quarter (25%) of all U.S. medical and health R&D at USD61.5 billion, with the National Institutes of Health (NIH) alone accounting for 20% (USD48.9 billion) of all such investment in 2020. At this level, NIH is the second largest funder of medical and health research after the biopharmaceutical industry. However, Increased government funding can provide researchers and institutions with more resources to conduct research on immune repertoire sequencing. Europe and the Asia Pacific are expected to expand significant growth during the forecast period, due to increasing research and development and launches of novel products.

Immune Repertoire Sequencing Market- Competitive Landscape:

The demand for immune repertoire sequencing has been steadily increasing due to its vital role in understanding the immune system, disease progression, and developing personalized therapies. The companies provide sequencing instruments, reagents, and software solutions for immune repertoire analysis. The immune repertoire sequencing market is competitive, with a range of companies and research institutions driving innovation and providing solutions for sequencing and analyzing immune repertoires. Advancements in sequencing technologies, bioinformatics tools, and data analysis methods continue to shape the competitive landscape and contribute to the growth of the market. For example, in 2023, Thermo Fisher Scientific announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T-cells and B-cells, which play a key role in the immune response system.

Recent Developments:

Pfizer Inc. and Adaptive Biotechnologies Corporation have entered into a translational research collaboration to leverage next-generation sequencing of the adaptive immune system to advance Pfizer's growing immuno-oncology franchise. Under the terms of the agreement, Pfizer and Adaptive will seek to combine drug development and platform technology biomarker expertise to identify patients who may preferentially benefit from immunotherapy.

Key features of the study:

  • This proposed research study on Immune Repertoire Sequencing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Immune Repertoire Sequencing market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Immune Repertoire Sequencing market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Immune Repertoire Sequencing market
  • Impact of COVID-19 on Immune Repertoire Sequencing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Immune Repertoire Sequencing market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Immune Repertoire Sequencing market, we have also included competitive landscape and key innovator analysis for the Immune Repertoire Sequencing market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Immune Repertoire Sequencing market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Immune Repertoire Sequencing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET KEY PLAYERS

  • Illumina Inc.
  • Thermo Fisher Scientific
  • PacBio
  • CD Genomics
  • Agilent Technologies, Inc
  • F. Hoffmann-La Roche Ltd
  • BGI Group Guangdong
  • Takara Bio, Inc.
  • Adaptive Biotechnologies
  • Juno Therapeutics
  • Atreca, Inc.
  • irepertoire, Inc.

GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT TYPE

  • Instruments
  • Assay Kits

GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION

  • Cancer Immunotherapy
  • Biomarker Discovery
  • Autoimmune Diseases
  • Vaccine Development and Efficacy
  • Transplant Rejection and Tolerance
  • Infectious Diseases
  • Others

GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Immune Repertoire Sequencing Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immune Repertoire Sequencing Market Snippet by Product Type
    • 2.1.2. Immune Repertoire Sequencing Market Snippet by Application
    • 2.1.3. Immune Repertoire Sequencing Market Snippet by Country
    • 2.1.4. Immune Repertoire Sequencing Market Snippet by Region
  • 2.2. Competitive Insights

3. Immune Repertoire Sequencing Key Market Trends

  • 3.1. Immune Repertoire Sequencing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immune Repertoire Sequencing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immune Repertoire Sequencing Market Opportunities
  • 3.4. Immune Repertoire Sequencing Market Future Trends

4. Immune Repertoire Sequencing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immune Repertoire Sequencing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Immune Repertoire Sequencing Market Landscape

  • 6.1. Immune Repertoire Sequencing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immune Repertoire Sequencing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Instruments
    • 7.1.3. Assay Kits

8. Immune Repertoire Sequencing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Cancer Immunotherapy
    • 8.1.3. Biomarker Discovery
    • 8.1.4. Autoimmune Diseases
    • 8.1.5. Vaccine Development and Efficacy
    • 8.1.6. Transplant Rejection and Tolerance
    • 8.1.7. Infectious Diseases
    • 8.1.8. Others

9. Immune Repertoire Sequencing Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Immune Repertoire Sequencing Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Immune Repertoire Sequencing Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Immune Repertoire Sequencing Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Immune Repertoire Sequencing Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Immune Repertoire Sequencing Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Immune Repertoire Sequencing Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Illumina Inc.
    • 10.2.2. Thermo Fisher Scientific
    • 10.2.3. PacBio
    • 10.2.4. CD Genomics
    • 10.2.5. Agilent Technologies, Inc
    • 10.2.6. F. Hoffmann-La Roche Ltd
    • 10.2.7. BGI Group Guangdong
    • 10.2.8. Takara Bio, Inc.
    • 10.2.9. Adaptive Biotechnologies
    • 10.2.10. Juno Therapeutics
    • 10.2.11. Atreca, Inc.
    • 10.2.12. irepertoire, Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us